Plasma concentration of soluble intercellular adhesion molecule-1 (sICAM-1) is elevated in type 2 diabetic patients, and sICAM-1 synthesis is associated with leptin-induced activation of the mitogen-activated protein kinase (MAPK) pathway

Inflammation

Volumn 36, Issue 4, 2013, Pages 878-887

  Cha, Jin Joo ^a   Hyun, Young Youl ^b   Jee, Yi Hwa ^a   Lee, Mi Jin ^a   Han, Kum Hyun ^c   Kang, Young Sun ^a   Han, Sang Youb ^c   Cha, Dae Ryong ^a  

^a Korea University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Inje University   (South Korea)

Author keywords

diabetic nephropathy; HUVECs; ICAM 1; leptin; type 2 diabetic patients

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALBUMIN; CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; SOLUBLE INTERCELLULAR ADHESION MOLECULE 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; HUMAN CELL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION;

ALBUMINURIA; BLOOD GLUCOSE; BODY MASS INDEX; CELLS, CULTURED; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENZYME ACTIVATION; FASTING; FEMALE; FLAVONOIDS; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LEPTIN; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS;

EID: 84880269832     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9615-1     Document Type: Article

References (28)

1. Eckel, R.H.; S.M. Grundy, and P.Z. Zimmet. 2005. The metabolic syndrome. Lancet 365: 1415-1428.
2. Lau, D.C.; B. Dhillon, H. Yan, P.E. Szmitko, and S. Verma. 2005. Adipokines: molecular links between obesity and atherosclerosis. American Journal of Physiology. Heart and Circulatory Physiology 288: H2031-H2041.
3. Ross, R. 1999. Atherosclerosis - an inflammatory disease. The New England Journal of Medicine 340: 115-126.
4. Jang, Y.; A.M. Lincoff, E.F. Plow, and E.J. Topol. 1994. Cell adhesion molecules in coronary artery disease. Journal of the American College of Cardiology 24: 1591-1601.
5. Kevil, C.G.; R.P. Patel, and D.C. Bullard. 2001. Essential role of ICAM-1 in mediating monocyte adhesion to aortic endothelial cells. American Journal of Physiology. Cell Physiology 281: C1442-C1447.
6. Kent Jr.; J.W.; A.G. Comuzzie, M.C. Mahaney, L. Almasy, D.L. Rainwater, J.L. VandeBerg, J.W. MacCluer, and J. Blangero. 2004. Intercellular adhesion molecule-1 concentration is genetically correlated with insulin resistance, obesity, and HDL concentration in Mexican Americans. Diabetes 53: 2691-2695.
7. El Amine, M.; S. Sohawon, L. Lagneau, N. Gaham, and S. Noordally. 2010. Plasma levels of ICAM-1 and circulating endothelial cells are elevated in unstable types 1 and 2 diabetes. Endocrine Regulations 44: 17-24.
8. Clausen, P.; P. Jacobsen, K. Rossing, J.S. Jensen, H.H. Parving, and B. Feldt-Rasmussen. 2000. Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabetic Medicine 17: 644-649.
9. Taki, H.; A. Kashiwagi, Y. Tanaka, and K. Horiike. 1996. Expression of intercellular adhesion molecules 1 (ICAM-1) via an osmotic effect in human umbilical vein endothelial cells exposed to high glucose medium. Life Science 58: 1713-1721.
10. Piconi, L.; L. Quagliaro, R. Da Ros, R. Assaloni, D. Giugliano, K. Esposito, C. Szabó, and A. Ceriello. 2004. Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. Journal of Thrombosis and Haemostasis 2: 1453-1459.
11. Zhang, Y.; R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.
12. Beltowski, J. 2006. Leptin and atherosclerosis. Atherosclerosis 189: 47-60.
13. Wallace, A.M.; A.D. McMahon, C.J. Packard, A. Kelly, J. Shepherd, A. Gaw, and N. Sattar. 2001. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104: 3052-3056.
14. Sierra-Johnson, J.; A. Romero-Corral, F. Lopez-Jimenez, A.S. Gami, F.H. Sert Kuniyoshi, R. Wolk, and V.K. Somers. 2007. Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population. The American Journal of Cardiology 100: 234-239.
15. Soderberg, S.; B. Stegmayr, H. Stenlund, L.G. Sjöström, A. Agren, L. Johansson, L. Weinehall, and T. Olsson. 2004. Leptin, but not adiponectin, predicts stroke in males. Journal of Internal Medicine 256: 128-136.
16. Schafer, K.; M. Halle, C. Goeschen, C. Dellas, M. Pynn, D.J. Loskutoff, and S. Konstantinides. 2004. Leptin promotes vascular remodeling and neointimal growth in mice. Arteriosclerosis, Thrombosis, and Vascular Biology 24: 112-117.
17. Bodary, P.F.; S. Gu, Y. Shen, A.H. Hasty, J.M. Buckler, and D.T. Eitzman. 2005. Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 25: e119-e122.
18. Bouloumie, A.; T. Marumo, M. Lafontan, and R. Busse. 1999. Leptin induces oxidative stress in human endothelial cells. The FASEB Journal 13: 1231-1238.
19. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 (Suppl 1): S5-S20.
20. Kishida, K.; T. Funahashi, and I. Shimomura. 2011. Clinical significance of visceral fat reduction through health education in preventing atherosclerotic cardiovascular disease - lesson from the Amagasaki Visceral Fat Study: a Japanese perspective. Nutrition and Metabolism 16: 8-57.
21. Ferrante, A.W. 2007. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. Journal of Internal Medicine 262: 408-414.
22. Ross, R. 1999. Atherosclerosis is an inflammatory disease. American Heart Journal 138: S419-420.
23. Park, E.; M.J. Shin, and N. Chung. 2007. The associations between serum leptin, adiponectin and intercellular adhesion molecule-1 in hypercholesterolemic patients. Nutrition Research and Practice 1: 65-69.
24. Longo, D.L.; and T.R. Harrison. 2012. Harrison's principles of internal medicine, 18th ed, 1983-1992. New York: McGraw-Hill.
25. Li, L.; J.C. Mamputu, N. Wiernsperger, and G. Renier. 2005. Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. Diabetes 54: 2227-2234.
26. Isenovic, E.R.; M.H. Kedees, M.A. Haidara, A. Trpkovic, D.P. Mikhailidis, and P. Marche. 2010. Involvement of ERK1/2 kinase in insulin-and thrombin-stimulated vascular smooth muscle cell proliferation. Angiology 61: 357-364.
27. Allman, M.; M. Wallace, L. Gaskin, and C.A. Rivera. 2009. Leptin induces an inflammatory phenotype in lean Wistar rats. Mediators of Inflammation 2009: 738620-738627.
28. Aleffi, S.; I. Petrai, C. Bertolani, M. Parola, S. Colombatto, E. Novo, F. Vizzutti, F.A. Anania, S. Milani, K. Rombouts, G. Laffi, M. Pinzani, and F. Marra. 2005. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 42: 1339-1348.